Stemmer Imaging: Corona pushes operating result into the red
Sales and earnings decline significantly in full-year 2020
In the 2020 financial year, Stemmer Imaging generated consolidated sales of 105.2 million euros, which is 12.8 percent less than in the previous year. The development of sales in 2020 was significantly influenced by the Corona pandemic, which led to a decline in sales in most of the major markets and industries. The operating result was -1.6 million euros (previous year: 7.5 million euros). After depreciation and amortization (EBITDA), the result was a plus of 7.2 million euros, 33 percent less than in 2019.
Incoming orders and sales increased in the second half of 2020
Order intake was particularly strong in the fourth quarter of 2020, with growth of 14 % compared to the first half of the year. Due in particular to a weak second quarter, the full-year figure was 113.9 million euros and thus nevertheless significantly below the previous year's figure of 119.4 million euros.
Sales also picked up in the second half of the year: While sales in the first half of the year were 52.3 million euros (previous year: 58.2), revenues in the second half rose to 53 million euros (previous year: 62.3).
Contract of CEO Dehn extended
Stemmer Imaging's Supervisory Board has reappointed Arne Dehn (51) as CEO for a further five years until the end of 2026, following the expiry of his current mandate at the end of 2021. Dehn was appointed to the Executive Board in January 2019.
Klaus Weinmann, Chairman of the Supervisory Board, comments: "In the past two years, Arne Dehn has set the decisive strategic course for further profitable growth. We are very pleased that with the reappointment of Arne Dehn, the positive development and further professionalization of the Group, together with Uwe Kemm, will continue."